(Q55073147)

English

Promising rationally derived combination therapy with PI3K and CDK4/6 inhibitors.

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25026206

retrieved

17 June 2018

reference URL

http://europepmc.org/abstract/MED/25026206

title

Promising rationally derived combination therapy with PI3K and CDK4/6 inhibitors. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25026206

retrieved

17 June 2018

reference URL

http://europepmc.org/abstract/MED/25026206

author

Taru Muranen

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25026206

retrieved

17 June 2018

reference URL

http://europepmc.org/abstract/MED/25026206

Funda Meric-Bernstam

series ordinal

2

object named as

Funda Meric-Bernstam

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17 June 2018

3

Gordon B Mills

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25026206

retrieved

17 June 2018

reference URL

http://europepmc.org/abstract/MED/25026206

publication date

1 July 2014

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25026206

retrieved

17 June 2018

reference URL

http://europepmc.org/abstract/MED/25026206

published in

Cancer Cell

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25026206

retrieved

17 June 2018

reference URL

http://europepmc.org/abstract/MED/25026206

volume

26

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25026206

retrieved

17 June 2018

reference URL

http://europepmc.org/abstract/MED/25026206

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25026206

retrieved

17 June 2018

reference URL

http://europepmc.org/abstract/MED/25026206

page(s)

7-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25026206

retrieved

17 June 2018

reference URL

http://europepmc.org/abstract/MED/25026206

Identifiers

DOI

10.1016/J.CCR.2014.06.020

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25026206

retrieved

17 June 2018

reference URL

http://europepmc.org/abstract/MED/25026206

Fatcat ID

release_hxsslwjxuzfhvparytvdm3xrgi

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/hxsslwjxuzfhvparytvdm3xrgi

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

25026206

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25026206

retrieved

17 June 2018

reference URL

http://europepmc.org/abstract/MED/25026206

ResearchGate publication ID

263936907

0 references

(Q55073147)

Promising rationally derived combination therapy with PI3K and CDK4/6 inhibitors.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)